Work

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Year: 2015

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv543

Authors: H.H. Yoon, N.R. Foster, J.P. Meyers, P.D. Steen, D.W. Visscher, R. Pillai, D.M. Prow, C.M. Reynolds, B.T. Marchello, R.B. Mowat, B.I. Mattar, C. Erlichman, M.P. Goetz

Institutions: Mayo Clinic, Iowa Oncology Research Association, Michigan Cancer Research Consortium, Montana Cancer Consortium

Language: English

Topic: Cancer Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: Alliance Statistics and Data Management Center, North Central Cancer Treatment Group, NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care, Alliance for Clinical Trials in Oncology Operations Center, Mayo Clinic Comprehensive Cancer Center Support Grant, The Alliance NCTN Biorepository and Biospecimen Resource

OpenAlex ID: W2200767375

FWCI: 1.729

Cites: 28

Cited by: 52

Related to: 10